For much of modern medical history, healthcare has relied on a simple principle: if patients share the same diagnosis, they are likely to benefit from the same treatment. This “average patient” model emerged from large clinical trials and population studies that identify therapies that work for the majority of people. While this approach helped establish reliable standards of care, doctors and researchers are increasingly recognizing that it has important limitations.

Advances in genetics, data science, and medical research are revealing a more complex picture of human health. Patients who appear similar on the surface often have very different biological profiles, lifestyle factors, and disease mechanisms.

As a result, healthcare is gradually shifting toward approaches that focus less on the average and more on the individual. Read on to learn more.

Where the “Average Patient” Model Came From

Traditional medicine developed around population-based research. Scientists would study large groups of patients with the same disease and identify treatments that produced the best overall outcomes. These results were then used to create standard treatment guidelines.

This model worked well for many conditions, especially infectious diseases or illnesses with clear biological causes. However, it assumes that patients within a diagnostic category are broadly similar. In reality, human biology varies significantly between individuals, which means treatments that work well on average may not work equally well for everyone.

Researchers have increasingly questioned whether this framework can fully address complex diseases such as cancer, autoimmune disorders, or chronic inflammatory conditions, where underlying causes can differ dramatically between patients.

The Problem With Treating the “Average”

One of the key reasons the average patient model is being reconsidered is that it can overlook important individual differences. Two people diagnosed with the same condition may respond very differently to the same medication.

Genetics plays a major role in this variation. Small differences in DNA can influence how a drug is absorbed, processed, or eliminated by the body. These differences can affect both the effectiveness of a treatment and the likelihood of side effects.

Because of this variability, a medication that works well for many patients might provide little benefit for others. The “average result” observed in clinical trials does not always reflect how individual patients will respond in real-world settings.

The Complexity of Human Biology

Another reason the average patient model is being reconsidered is that diseases themselves are often more complex than previously understood. What was once thought to be a single condition may actually consist of several subtypes with different biological causes.

For example, research has shown that cancers often vary significantly between patients, and even within a single tumour there can be multiple genetic mutations affecting how it grows and responds to treatment.

This complexity means that treating every patient with the same therapy may overlook important biological differences that could influence treatment outcomes.

Why Patient-Centered Care Is Becoming the Focus

Another factor driving change is the growing emphasis on patient-centered healthcare. Modern medicine increasingly recognizes that effective treatment must consider the whole person rather than just the disease.

Lifestyle, environmental exposure, mental wellbeing, and social circumstances can all influence health outcomes. Personalized healthcare approaches take these factors into account when designing treatment strategies.

This broader perspective allows doctors to move beyond standardized protocols and develop care plans that better reflect each patient’s needs and circumstances.

Healthcare providers and platforms such as Daydream MD illustrate this shift toward more individualized, patient-focused healthcare experiences, where medical decisions are guided by the specific needs and characteristics of each patient.

A Healthcare Model That Reflects Human Diversity

The reconsideration of the average patient model does not mean that traditional medicine was misguided. Standardized treatments have saved millions of lives and remain essential in many areas of healthcare.

However, scientific progress has revealed that human health is far more diverse and complex than previously understood. By recognizing these differences, doctors can refine treatment strategies and improve outcomes for patients who might otherwise fall outside the “average” response.

The future of healthcare is therefore likely to involve a balance between established medical guidelines and personalized insights. As research continues to uncover the many factors that shape individual health, medicine will increasingly focus on delivering care that reflects the unique biology, experiences, and needs of every patient.

Last modified: March 17, 2026